TR200001545T2 - Plazma proteini içeren farmasötik bileşimler. - Google Patents
Plazma proteini içeren farmasötik bileşimler.Info
- Publication number
- TR200001545T2 TR200001545T2 TR2000/01545T TR200001545T TR200001545T2 TR 200001545 T2 TR200001545 T2 TR 200001545T2 TR 2000/01545 T TR2000/01545 T TR 2000/01545T TR 200001545 T TR200001545 T TR 200001545T TR 200001545 T2 TR200001545 T2 TR 200001545T2
- Authority
- TR
- Turkey
- Prior art keywords
- plasma protein
- pharmaceutical compositions
- compositions containing
- containing plasma
- active substance
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 108010017384 Blood Proteins Proteins 0.000 title abstract 2
- 102000004506 Blood Proteins Human genes 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 238000004220 aggregation Methods 0.000 abstract 1
- 230000002776 aggregation Effects 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108010058237 plasma protein fraction Proteins 0.000 abstract 1
- 229940081857 plasma protein fraction Drugs 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bu bulus esasen parenteral kullanim için kati veya sivi formda suda çözünür ürünlere veya farmasötik formülasyonlara iliskindir. Terapötik olarak etkin bir madde (suda düsük çözünürlüge haiz ve plazma proteinine baglanma egilimi büyük ) ve kontrollü topaklanma halindeki bir plazma protein fraksiyonundan olusurlar veya bunlari ihtiva ederler. Sözü geçen etkin madde ve sözü geçen protein fraksiyonu birbirine kovalent olmayan baglar vasitasiyla baglanmistir. Bulus ürünün ve farmasötik formülasyonun hazirlanmasi için islemleri de kapsar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9701554A HUP9701554D0 (en) | 1997-09-18 | 1997-09-18 | Pharmaceutical composition containing plazma proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200001545T2 true TR200001545T2 (tr) | 2000-10-23 |
Family
ID=90014222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/01545T TR200001545T2 (tr) | 1997-09-18 | 1998-09-17 | Plazma proteini içeren farmasötik bileşimler. |
Country Status (33)
Country | Link |
---|---|
US (5) | US6743826B1 (tr) |
EP (1) | EP0981375B1 (tr) |
JP (1) | JP2001508806A (tr) |
KR (1) | KR100587962B1 (tr) |
CN (1) | CN1189216C (tr) |
AR (1) | AR017120A1 (tr) |
AT (1) | ATE230611T1 (tr) |
AU (1) | AU734695B2 (tr) |
BG (1) | BG64749B1 (tr) |
BR (1) | BR9812469A (tr) |
CA (1) | CA2269923C (tr) |
CZ (1) | CZ301326B6 (tr) |
DE (1) | DE69810612T2 (tr) |
DK (1) | DK0981375T3 (tr) |
EA (1) | EA004700B1 (tr) |
ES (1) | ES2187062T3 (tr) |
HR (1) | HRP980499A2 (tr) |
HU (1) | HUP9701554D0 (tr) |
IL (1) | IL135055A (tr) |
LT (1) | LT4736B (tr) |
LV (1) | LV12493B (tr) |
NO (1) | NO325294B1 (tr) |
NZ (1) | NZ503302A (tr) |
PL (1) | PL193067B1 (tr) |
PT (1) | PT981375E (tr) |
RO (1) | RO118695B1 (tr) |
RS (1) | RS50102B (tr) |
SI (1) | SI20189B (tr) |
SK (1) | SK284683B6 (tr) |
TR (1) | TR200001545T2 (tr) |
TW (1) | TWI222365B (tr) |
WO (1) | WO1999013914A1 (tr) |
ZA (1) | ZA988585B (tr) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US8137684B2 (en) * | 1996-10-01 | 2012-03-20 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
HUP9701554D0 (en) * | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
AU2530700A (en) * | 1999-02-11 | 2000-08-29 | Kinetana Inc. | Serum albumin-based parenteral formulations of polyene macrolides |
ATE306942T1 (de) | 1999-09-16 | 2005-11-15 | Novo Nordisk As | Zusammensetzung zur in-vitro befruchtung |
JP2004507451A (ja) * | 2000-04-10 | 2004-03-11 | テバ ファーマシューティカル インダストリーズ リミティド | アポトーシス誘導性化学療法剤の投与による癌の治療のための方法及び組成物 |
AU2001253336A1 (en) * | 2000-04-10 | 2001-10-23 | Teva Pharmaceutical Industries Ltd. | Method 0f administration of paclitaxel-plasma protein formulation |
WO2002087563A2 (en) * | 2001-05-01 | 2002-11-07 | Angiotech Pharmaceuticals Inc. | Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions |
PT1463751E (pt) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Proteínas de fusão de albumina |
GR1004274B (el) | 2002-07-16 | 2003-06-23 | Medexis ���� | Συμπλοκα στεροειδων ορμονων με πρωτεινες: νεες ουσιες για την ειδικη ανιχνευση και καταστροφη καρκινικων κυτταρων προερχομενων απο στερεους ογκους και αιματολογικες κακοηθειες |
MXPA05000615A (es) | 2002-07-16 | 2005-11-17 | Medexis S A | Conjugados esteroideos, preparacion de los mismos y usos de los mismos. |
JPWO2004024188A1 (ja) * | 2002-09-12 | 2006-01-05 | 日本メジフィジックス株式会社 | 薬物の血漿蛋白質結合を制御するための製剤 |
KR20200083657A (ko) | 2002-12-09 | 2020-07-08 | 아브락시스 바이오사이언스, 엘엘씨 | 약리학적 물질의 조성물 및 그 전달방법 |
US20050079546A1 (en) * | 2003-05-01 | 2005-04-14 | Dasa Lipovsek | Serum albumin scaffold-based proteins and uses thereof |
US20040225022A1 (en) * | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
US7345093B2 (en) | 2004-04-27 | 2008-03-18 | Formatech, Inc. | Methods of enhancing solubility of compounds |
US7659310B2 (en) | 2004-04-27 | 2010-02-09 | Formatech, Inc. | Methods of enhancing solubility of agents |
US20050277584A1 (en) * | 2004-06-09 | 2005-12-15 | Allergan, Inc. | Pharmaceutical compositions comprising cyclosporins |
EP1807146A4 (en) * | 2004-09-29 | 2013-07-03 | Tel Hashomer Medical Res Infrastructure & Services Ltd | COMPOSITION FOR IMPROVING THE EFFICACY OF DRUG DELIVERY |
US20060198891A1 (en) | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
JP2010523554A (ja) | 2007-04-04 | 2010-07-15 | シグモイド・ファーマ・リミテッド | タクロリムスの医薬組成物 |
CA2942083C (en) | 2007-04-26 | 2019-01-29 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
JPWO2009116557A1 (ja) * | 2008-03-21 | 2011-07-21 | 富士フイルム株式会社 | 薬剤含有組成物 |
CN101658516B (zh) * | 2008-08-26 | 2011-10-05 | 齐鲁制药有限公司 | 紫杉醇类药物组合物及其制备方法 |
SI2432455T1 (sl) | 2009-05-18 | 2015-04-30 | Sigmoid Pharma Limited | Sestava, obsegajoäśa oljne kapljice |
WO2011018504A2 (en) | 2009-08-12 | 2011-02-17 | Sigmoid Pharma Limited | Immunomodulatory compositions comprising a polymer matrix and an oil phase |
US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
US9402812B2 (en) | 2009-09-23 | 2016-08-02 | Indu JAVERI | Methods for the preparation of liposomes |
RU2589697C2 (ru) * | 2009-12-18 | 2016-07-10 | Экзодос Лайф Сайенсиз Лимитед Партнершип | Способы получения стабильных жидких лекарственных препаратов и их композиции |
EP2531173B1 (en) * | 2010-02-03 | 2018-09-26 | Oncbiomune, L.L.C. | Taxane- and taxoid-protein compositions |
AR093275A1 (es) | 2010-03-17 | 2015-05-27 | Centro De Excelencia En Productos Y Procesos De Cordoba (Ceprocor) | Una composicion farmaceutica soluble en agua que comprende al menos una sustancia terapeuticamente activa de caracteristicas hidrofobicas y al menos un compuesto seleccionado entre los sialoglicoesfingolipidos, los glicoesfingolipidos o una mezcla de sialoglicoesfingolipidos y glicoesfingolipidos |
GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
EP3119391B1 (en) * | 2014-03-18 | 2024-08-07 | Izun Pharmaceuticals Corp. | Protein-bound cannabinoid compositions |
KR20170102223A (ko) | 2014-11-07 | 2017-09-08 | 시그모이드 파마 리미티드 | 사이클로스포린을 포함하는 조성물 |
AR100034A1 (es) | 2015-01-30 | 2016-09-07 | Consejo Nac De Investig Científicas Y Técnicas (Conicet) | Una composición farmacéutica soluble en agua que comprende, al menos, una sustancia terapéuticamente activa y, al menos, una sustancia con capacidad para formar micelas |
EP3978618A1 (en) * | 2015-05-08 | 2022-04-06 | Spectral Platforms, Inc. | Albumin-based non-covalent complexes and methods of use thereof |
WO2016187147A1 (en) * | 2015-05-15 | 2016-11-24 | Fl Therapeutics Llc | Docetaxel and human serum albumin complexes |
KR20180014790A (ko) * | 2015-06-18 | 2018-02-09 | 마티나스 바이오파마 나노테크놀로지스, 인코포레이티드 | 염증성 질환 또는 병태를 치료하기 위한 조성물 및 방법 |
US20170128480A1 (en) * | 2015-11-09 | 2017-05-11 | Max A. Cayo | Cardiac Glycosides for the Treatment of Hypercholesterolemia |
EP3493815B1 (en) * | 2016-08-03 | 2022-02-16 | Zhuhai Beihai Biotech Co., Ltd. | Formulations of fosaprepitant and aprepitant |
CN110062622B (zh) | 2016-10-27 | 2022-10-14 | 珠海贝海生物技术有限公司 | 多西他赛和人血清白蛋白的中性pH组合物 |
KR20190122256A (ko) | 2017-03-09 | 2019-10-29 | 이준 파마슈티컬스 코퍼레이션 | 안정화된 단백질-결합 칸나비노이드 조성물 |
MX2019011119A (es) | 2017-03-20 | 2019-12-19 | Spectral Platforms Inc | Metodos espectroscopicos para detectar y caracterizar microorganismos. |
CA3069004A1 (en) | 2017-07-07 | 2019-01-10 | Epicentrx, Inc. | Compositions for parenteral administration of therapeutic agents |
KR102496934B1 (ko) * | 2018-03-09 | 2023-02-06 | 판옵테스 파르마 게스.엠.베.하. | 안과용 제제 |
EP3811982A1 (en) * | 2019-10-25 | 2021-04-28 | Université de Strasbourg | Protein-based biomaterial with viscoelastic behaviour, process for obtaining it and uses thereof |
CN111529506B (zh) * | 2020-05-18 | 2021-09-03 | 同济大学 | 一种两性霉素b白蛋白纳米制剂及其制备方法和应用 |
US11739166B2 (en) | 2020-07-02 | 2023-08-29 | Davol Inc. | Reactive polysaccharide-based hemostatic agent |
JP7497448B2 (ja) * | 2021-06-29 | 2024-06-10 | ジンセル・バイオテック・インコーポレイテッド | アルブミンを高効率に生産する植物細胞株及びその用途 |
CN114544926A (zh) * | 2021-12-02 | 2022-05-27 | 浙江鑫科医疗科技有限公司 | 一种血清蛋白稳定剂 |
CN115236216B (zh) * | 2022-06-07 | 2024-03-01 | 合肥和合医疗科技有限公司 | 高效液相色谱串联质谱检测全血中免疫抑制剂的试剂盒,其制备方法和检测方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4833013A (tr) * | 1971-08-30 | 1973-05-07 | ||
DE2653534C2 (de) * | 1975-12-22 | 1986-08-28 | Baxter Travenol Laboratories, Inc., Deerfield, Ill. | Feste Antihämophilen-Faktor-Präparation und Verfahren zu ihrer Herstellung |
JPS58216126A (ja) * | 1982-06-11 | 1983-12-15 | Ono Pharmaceut Co Ltd | 可容化製剤 |
DE3702105A1 (de) | 1987-01-24 | 1988-08-04 | Bayer Ag | Parenterale loesung |
US5051406A (en) * | 1987-03-04 | 1991-09-24 | Nippon Hypox Laboratories Incorporated | Pharmaceutical composition using albumin as a carrier and process for producing the same |
JPS63215640A (ja) * | 1987-03-04 | 1988-09-08 | Nippon Hai Potsukusu:Kk | 易吸収性抗炎症剤及びその製造方法 |
CA2086874E (en) | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
US5356927A (en) * | 1992-12-02 | 1994-10-18 | Thomas Jefferson University | Methods of treating plasmodium and babesia parasitic infections |
US5439686A (en) | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
GB9510716D0 (en) * | 1995-05-26 | 1995-07-19 | Pharmacia Spa | Substituted camptothecin derivatives and process for their preparation |
TR199600775A2 (tr) | 1996-09-27 | 1997-09-21 | Tureks Turunc Madencilik Ic Ve | Taslara eskitilmis görüntü kazandirilmasi icin bir yöntem. |
US5776912A (en) * | 1996-12-20 | 1998-07-07 | Schering Corporation | Lipophilic oligosaccharide antibiotic compositions |
HUP9701554D0 (en) * | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
-
1997
- 1997-09-18 HU HU9701554A patent/HUP9701554D0/hu unknown
-
1998
- 1998-09-10 HR HRP9701554A patent/HRP980499A2/hr not_active Application Discontinuation
- 1998-09-17 SK SK329-2000A patent/SK284683B6/sk not_active IP Right Cessation
- 1998-09-17 DK DK98946629T patent/DK0981375T3/da active
- 1998-09-17 WO PCT/HU1998/000086 patent/WO1999013914A1/en not_active Application Discontinuation
- 1998-09-17 NZ NZ503302A patent/NZ503302A/en unknown
- 1998-09-17 JP JP51757699A patent/JP2001508806A/ja not_active Withdrawn
- 1998-09-17 KR KR1020007002810A patent/KR100587962B1/ko not_active IP Right Cessation
- 1998-09-17 PT PT98946629T patent/PT981375E/pt unknown
- 1998-09-17 AT AT98946629T patent/ATE230611T1/de active
- 1998-09-17 EA EA200000331A patent/EA004700B1/ru not_active IP Right Cessation
- 1998-09-17 BR BR9812469-2A patent/BR9812469A/pt not_active Application Discontinuation
- 1998-09-17 SI SI9820067A patent/SI20189B/sl active Search and Examination
- 1998-09-17 ES ES98946629T patent/ES2187062T3/es not_active Expired - Lifetime
- 1998-09-17 DE DE69810612T patent/DE69810612T2/de not_active Expired - Lifetime
- 1998-09-17 PL PL339369A patent/PL193067B1/pl unknown
- 1998-09-17 CN CNB988092514A patent/CN1189216C/zh not_active Expired - Fee Related
- 1998-09-17 IL IL13505598A patent/IL135055A/en not_active IP Right Cessation
- 1998-09-17 RS YUP-166/00A patent/RS50102B/sr unknown
- 1998-09-17 RO ROA200000315A patent/RO118695B1/ro unknown
- 1998-09-17 TR TR2000/01545T patent/TR200001545T2/tr unknown
- 1998-09-17 AU AU93623/98A patent/AU734695B2/en not_active Ceased
- 1998-09-17 CA CA002269923A patent/CA2269923C/en not_active Expired - Lifetime
- 1998-09-17 CZ CZ20000952A patent/CZ301326B6/cs not_active IP Right Cessation
- 1998-09-17 EP EP98946629A patent/EP0981375B1/en not_active Expired - Lifetime
- 1998-09-18 AR ARP980104659A patent/AR017120A1/es not_active Application Discontinuation
- 1998-09-18 ZA ZA9808585A patent/ZA988585B/xx unknown
- 1998-09-18 TW TW087115619A patent/TWI222365B/zh not_active IP Right Cessation
-
1999
- 1999-04-27 US US09/299,562 patent/US6743826B1/en not_active Expired - Lifetime
-
2000
- 2000-03-14 LV LVP-00-38A patent/LV12493B/en unknown
- 2000-03-16 NO NO20001371A patent/NO325294B1/no not_active IP Right Cessation
- 2000-03-16 BG BG104245A patent/BG64749B1/bg unknown
- 2000-03-17 LT LT2000018A patent/LT4736B/lt not_active IP Right Cessation
-
2003
- 2003-01-21 US US10/349,492 patent/US7119124B2/en not_active Expired - Lifetime
-
2004
- 2004-03-17 US US10/802,528 patent/US7501455B2/en not_active Expired - Fee Related
-
2006
- 2006-10-10 US US11/546,518 patent/US20070232536A1/en not_active Abandoned
-
2009
- 2009-02-09 US US12/322,997 patent/US8946167B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200001545T2 (tr) | Plazma proteini içeren farmasötik bileşimler. | |
ATE324907T1 (de) | Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen | |
TR199701071T2 (tr) | Aktif madde ulastirmaya mahsus bilesikler ve terkipler. | |
PT910353E (pt) | Administracao transdermica de farmacos basicos utilizando sistemas adesivos naopolares e agentes de solubilizacao acidos | |
ATE429210T1 (de) | Orale flüssige zusammensetzungen | |
EP1077070A3 (en) | Oral drug delivery compositions | |
DE69531741D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
HUP0001170A3 (en) | Pharmaceutical compositions containing benzimidazole-2-carbamate derivatives as active ingredients for the treatment of viral infections and cancer | |
IL172835A0 (en) | A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids | |
NZ512792A (en) | Stable liquid interferon beta formulations | |
IL94433A0 (en) | Aminophenol derivatives,their preparation and pharmaceutical compositions containing them | |
CA2361402A1 (en) | Bis-sulfonamides | |
PT1079849E (pt) | Utilizacao de proteinas hmg para a preparacao de medicamentos com actividade citotoxica | |
BRPI0606396A2 (pt) | sulfonas tripeptìdicas e tetrapeptìdicas, composição farmacêutica contendo as mesmas, uso relacionado e método de preparação das referidas sulfonas | |
AU7683296A (en) | Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them | |
Burzynski et al. | Biological active peptides in human urine: III. Inhibitors of the growth of human leukemia, osteosarcoma, and HeLa cells | |
ATE199641T1 (de) | Terpenderivate (sarcodictyine) als antikrebsmittel | |
DE69602886D1 (de) | Im kardiovaskulären System aktive seco-D-Steroide und diese enthaltende pharmazeutische Zubereitungen | |
AU2003224107A1 (en) | Soluble composition containing sporopollenin and the use thereof | |
HUP0202630A2 (hu) | Meiózisra ható anyagokat tartalmazó készítmények | |
IL105454A0 (en) | Water-soluble retinoids,their preparation and pharmaceutical and cosmetic compositions containing them | |
EP1051966A3 (de) | Kosmetische und/oder pharmazeutische Zubereitungen mit einem Gehalt an Alkyl- und/oder Alkenyloligoglykosiden, Fettsäurepartialglyceriden, Esterquats und hydroxyalkylertem Guar als Verdickungsmittel | |
DE69636983D1 (de) | Stoffe und zusammensetzungen für die verabreichung aktiver substanzen | |
RU94046405A (ru) | Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок | |
UA39712A (uk) | Композиція для очних крапель, що містить інтерферон, та очні краплі на її основі |